Antibiotics with Good Brain Penetration for CNS Infections

First-Line Agents with Excellent CNS Penetration

The Infectious Diseases Society of America recommends ceftriaxone and cefotaxime as first-line therapy for bacterial meningitis and brain abscess, achieving adequate CSF concentrations 1, 2
Third-generation cephalosporins demonstrate superior outcomes compared to second-generation cephalosporins and chloramphenicol, with established efficacy in clinical trials 1
Ceftazidime should be considered specifically when Pseudomonas aeruginosa is suspected, such as in cases of chronic suppurative otitis media 2

The American Society of Health-System Pharmacists suggests that meropenem demonstrates clinical and microbiologic outcomes equivalent to ceftriaxone/cefotaxime and is recommended as an alternative first-line agent for CNS infections 1, 2
Meropenem is strongly preferred over imipenem due to significantly lower seizure risk, with imipenem causing seizures in a significant portion of pediatric meningitis cases 1
For gram-negative CNS infections, particularly those producing extended-spectrum β-lactamases, meropenem is the recommended agent 1, 2
Metronidazole is an essential component of empirical therapy for brain abscess due to excellent anaerobic coverage 2
Linezolid achieves 66% CSF penetration, making it superior to vancomycin for CNS infections when IV therapy alone is used, and is preferred over vancomycin for MRSA CNS infections due to superior pharmacokinetic properties 2, 3
Rifampin demonstrates good CSF penetration and in vitro activity against many meningeal pathogens, but must never be used as monotherapy due to rapid resistance development 1, 3

Vancomycin has poor CSF penetration and should never be used as monotherapy for CNS infections, but may be combined with third-generation cephalosporin for resistant pneumococcal meningitis 1, 3
Ceftazidime-Avibactam is a first-line treatment for OXA-48-like producing carbapenem-resistant Enterobacterales CNS infections, with recommended therapeutic drug monitoring of both blood and CSF 4

Colistin requires intrathecal/intraventricular administration in addition to systemic therapy due to poor penetration 4
Surgical intervention, such as shunt removal or abscess drainage, must be performed whenever possible, as antimicrobial therapy alone has poor outcomes for device-related CNS infections 3, 4